Literature DB >> 22706320

Exhaled breath condensate pH in patients with cystic fibrosis.

Balazs Antus1, Imre Barta, Eszter Csiszer, Krisztina Kelemen.   

Abstract

OBJECTIVE AND
DESIGN: Exhaled breath condensate (EBC) pH has been proposed as a useful, non-invasive marker of airway inflammation in pulmonary diseases. In this study we tested whether cystic fibrosis (CF) is associated with acidification of EBC, when pH is assessed by the CO(2) gas standardization method.
METHODS: EBC was collected using two different devices (EcoScreen and R-Tube) in 46 stable CF patients during routine clinical visits and in 28 healthy controls.
RESULTS: Mean EBC pH in CF patients and in healthy controls was similar (EcoScreen: CF patients: 6.38 ± 0.03 versus controls: 6.39 ± 0.03, p = 0.699; R-tube: CF patients: 5.94 ± 0.04 versus controls: 6.02 ± 0.03, p = 0.159). Inflammatory cell counts in spontaneously expectorated sputum obtained in a subset of patients (n = 20) showed no correlation with pH values. EBC samples collected with the R-tube were more acidic than those collected with the EcoScreen device (p < 0.001).
CONCLUSIONS: Our data suggest that EBC pH does not discriminate between healthy controls and those with CF disease indicating that the clinical applicability of EBC pH measurements for assessing airway inflammation in CF is limited.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22706320     DOI: 10.1007/s00011-012-0508-9

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  34 in total

1.  Exhaled breath condensate pH is a robust and reproducible assay of airway acidity.

Authors:  J Vaughan; L Ngamtrakulpanit; T N Pajewski; R Turner; T A Nguyen; A Smith; P Urban; S Hom; B Gaston; J Hunt
Journal:  Eur Respir J       Date:  2003-12       Impact factor: 16.671

2.  Exhaled breath condensate: methodological recommendations and unresolved questions.

Authors:  I Horváth; J Hunt; P J Barnes; K Alving; A Antczak; E Baraldi; G Becher; W J C van Beurden; M Corradi; R Dekhuijzen; R A Dweik; T Dwyer; R Effros; S Erzurum; B Gaston; C Gessner; A Greening; L P Ho; J Hohlfeld; Q Jöbsis; D Laskowski; S Loukides; D Marlin; P Montuschi; A C Olin; A E Redington; P Reinhold; E L J van Rensen; I Rubinstein; P Silkoff; K Toren; G Vass; C Vogelberg; H Wirtz
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

3.  Exhaled breath condensate pH in lung transplant recipients with bronchiolitis obliterans syndrome.

Authors:  Szabolcs Soter; Krisztina Kelemen; Imre Barta; Marta Valyon; Eszter Csiszer; Balazs Antus
Journal:  Transplantation       Date:  2011-04-15       Impact factor: 4.939

4.  Airways in cystic fibrosis are acidified: detection by exhaled breath condensate.

Authors:  S Tate; G MacGregor; M Davis; J A Innes; A P Greening
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

5.  Sputum induction as a research tool for sampling the airways of subjects with cystic fibrosis.

Authors:  N R Henig; M R Tonelli; M V Pier; J L Burns; M L Aitken
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

6.  Exhaled breath condensate pH standardised for CO2 partial pressure.

Authors:  T Kullmann; I Barta; Z Lázár; B Szili; E Barát; M Valyon; M Kollai; I Horváth
Journal:  Eur Respir J       Date:  2006-11-01       Impact factor: 16.671

7.  IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children.

Authors:  A Bodini; C D'Orazio; D G Peroni; M Corradi; L Zerman; G Folesani; B M Assael; A L Boner; G L Piacentini
Journal:  Int J Immunopathol Pharmacol       Date:  2007 Jul-Sep       Impact factor: 3.219

8.  Breath condensate pH in children with cystic fibrosis and asthma: a new noninvasive marker of airway inflammation?

Authors:  Giovanna E Carpagnano; Peter J Barnes; Jackie Francis; Nicola Wilson; Andrew Bush; Sergei A Kharitonov
Journal:  Chest       Date:  2004-06       Impact factor: 9.410

9.  Exhaled 8-isoprostane and prostaglandin E(2) in patients with stable and unstable cystic fibrosis.

Authors:  Vincenzina Lucidi; Giovanni Ciabattoni; Sergio Bella; Peter J Barnes; Paolo Montuschi
Journal:  Free Radic Biol Med       Date:  2008-06-30       Impact factor: 7.376

10.  Variability of exhaled breath condensate pH in lung transplant recipients.

Authors:  Krisztina Czebe; Tamas Kullmann; Eszter Csiszer; Erzsebet Barat; Ildiko Horvath; Balazs Antus
Journal:  Respiration       Date:  2008       Impact factor: 3.580

View more
  7 in total

1.  Neonates with cystic fibrosis have a reduced nasal liquid pH; a small pilot study.

Authors:  Mahmoud H Abou Alaiwa; Alison M Beer; Alejandro A Pezzulo; Janice L Launspach; Rebecca A Horan; David A Stoltz; Timothy D Starner; Michael J Welsh; Joseph Zabner
Journal:  J Cyst Fibros       Date:  2014-01-11       Impact factor: 5.482

2.  Comparison of Airway and Systemic Malondialdehyde Levels for Assessment of Oxidative Stress in Cystic Fibrosis.

Authors:  Balazs Antus; Orsolya Drozdovszky; Imre Barta; Krisztina Kelemen
Journal:  Lung       Date:  2015-05-08       Impact factor: 2.584

3.  Predicting sputum eosinophilia in exacerbations of COPD using exhaled nitric oxide.

Authors:  Szabolcs Soter; Imre Barta; Balazs Antus
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

4.  Variability of breath condensate pH may contribute to the better understanding of non-allergic seasonal respiratory diseases.

Authors:  Tamás Kullmann; Annamária Szipőcs
Journal:  Int J Biometeorol       Date:  2017-07-05       Impact factor: 3.787

Review 5.  Exhaled Breath Condensate: Technical and Diagnostic Aspects.

Authors:  Efstathia M Konstantinidi; Andreas S Lappas; Anna S Tzortzi; Panagiotis K Behrakis
Journal:  ScientificWorldJournal       Date:  2015-05-27

6.  Elimination of bacterial DNA during RNA isolation from sputum: Bashing bead vortexing is preferable over prolonged DNase treatment.

Authors:  Csilla Paska; Imre Barta; Orsolya Drozdovszky; Balazs Antus
Journal:  PLoS One       Date:  2019-03-28       Impact factor: 3.240

Review 7.  Exhaled breath condensate--from an analytical point of view.

Authors:  Slavica Dodig; Ivana Cepelak
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.